Education
About Us
Working with TipRanks
Follow Us
Simulations Plus (SLP)
:SLP
SLP Analyst Ratings
Moderate Buy
3 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SLP Stock 12 Month Forecast
Average Price Target
$20.50
▲(18.43% Upside)
| Highest Price Target$25.00 | Average Price Target$20.50 | Lowest Price Target$16.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
$16
Hold
-7.57%
Downside
Reiterated
12/02/25
Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH) and Simulations Plus (NASDAQ: SLP)We expect Services will continue to see pullback until macro spending contractions resolve more fully (management is starting to see early signs of stabilization). Notably, recent investments into cloud deployment, interoperability and AI-enabled products (including integrated federated data sharing) should also drive continued Software strength as customers buy into the next-gen, AI- centric platform.
William Blair
―
Buy
―
Reiterated
12/02/25
Simulations Plus: Strategic Investments and Market Positioning Drive Buy RecommendationWe view the following as key risks for Simulations Plus in the next three to five years: 1) a material reduction in biotech funding; 2) mix-related margin erosion if service contracts outpace software sales; 3) lack of continued regulatory support for biosimulation or an inability to expand use-cases; and 4) an inability to attract or retain high-demand talent, particularly in artificial intelligence.
BTIG
$25
Buy
44.43%
Upside
Reiterated
12/02/25
Positive Outlook for Simulations Plus Amid Strong Financial Performance and Strategic Industry AlignmentWe worry that with seemingly stubborn headwinds impacting F1Q:26 results, it may be challenging to deliver on F2026 guidance, if the market remains under some pressure. Our model and estimates are under review.
Craig-Hallum
―
Buy
―
Reiterated
12/01/25
KeyBanc
―
Hold
―
Reiterated
10/29/25
Citizens JMP
―
Hold
―
Reiterated
07/15/25
Stephens
$28→$20
Buy
15.54%
Upside
Reiterated
07/15/25
LifeSci Capital
$65
Buy
275.51%
Upside
Reiterated
04/04/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
$16
Hold
-7.57%
Downside
Reiterated
12/02/25
Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH) and Simulations Plus (NASDAQ: SLP)We expect Services will continue to see pullback until macro spending contractions resolve more fully (management is starting to see early signs of stabilization). Notably, recent investments into cloud deployment, interoperability and AI-enabled products (including integrated federated data sharing) should also drive continued Software strength as customers buy into the next-gen, AI- centric platform.
William Blair
―
Buy
―
Reiterated
12/02/25
Simulations Plus: Strategic Investments and Market Positioning Drive Buy RecommendationWe view the following as key risks for Simulations Plus in the next three to five years: 1) a material reduction in biotech funding; 2) mix-related margin erosion if service contracts outpace software sales; 3) lack of continued regulatory support for biosimulation or an inability to expand use-cases; and 4) an inability to attract or retain high-demand talent, particularly in artificial intelligence.
BTIG
$25
Buy
44.43%
Upside
Reiterated
12/02/25
Positive Outlook for Simulations Plus Amid Strong Financial Performance and Strategic Industry AlignmentWe worry that with seemingly stubborn headwinds impacting F1Q:26 results, it may be challenging to deliver on F2026 guidance, if the market remains under some pressure. Our model and estimates are under review.
Craig-Hallum
―
Buy
―
Reiterated
12/01/25
KeyBanc
―
Hold
―
Reiterated
10/29/25
Citizens JMP
―
Hold
―
Reiterated
07/15/25
Stephens
$28→$20
Buy
15.54%
Upside
Reiterated
07/15/25
LifeSci Capital
$65
Buy
275.51%
Upside
Reiterated
04/04/25
Best Analysts Covering Simulations Plus
1 Month
xxx
Success Rate
14/24 ratings generated profit
Average Return
+4.78%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +4.78% per trade.
3 Months
xxx
Success Rate
11/29 ratings generated profit
Average Return
-6.08%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 37.93% of your transactions generating a profit, with an average return of -6.08% per trade.
1 Year
Success Rate
11/29 ratings generated profit
Average Return
-8.35%
reiterated a buy rating 7 days ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 37.93% of your transactions generating a profit, with an average return of -8.35% per trade.
2 Years
xxx
Success Rate
8/29 ratings generated profit
Average Return
-21.23%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 27.59% of your transactions generating a profit, with an average return of -21.23% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SLP Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
4
3
1
1
1
Buy
11
5
2
3
6
Hold
9
9
6
5
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
17
9
9
11
Each month's total comprises the sum of three months' worth of ratings.
SLP Financial Forecast
SLP Stock Forecast FAQ
What is SLP’s average 12-month price target, according to analysts?
Based on analyst ratings, Simulations Plus’s 12-month average price target is 20.50.
What is SLP’s upside potential, based on the analysts’ average price target?
Simulations Plus has 18.43% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SLP a Buy, Sell or Hold?
Simulations Plus has a consensus rating of Moderate Buy which is based on 3 buy ratings, 2 hold ratings and 0 sell ratings.
What is Simulations Plus’s price target?
The average price target for Simulations Plus is 20.50. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $16.00. The average price target represents 18.43% Increase from the current price of $17.31.
The highest analyst price target is $25.00 ,the lowest forecast is $16.00. The average price target represents 18.43% Increase from the current price of $17.31.
What do analysts say about Simulations Plus?
Simulations Plus’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of SLP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.